Jolanta Grys, - Pharmacist in Algonquin, IL

Jolanta Grys, is a Pharmacist based in Algonquin, Illinois. Jolanta Grys is licensed to practice in Illinois (license number 051.038010) and her current practice location is 107 S Randall Rd, Algonquin, Illinois. She can be reached at her office (for appointments etc.) via phone at (847) 854-8274.

NPI number for Jolanta Grys is 1083062202 and her current mailing address is 107 S Randall Rd, Algonquin, Illinois. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1083062202.

Contact Information

Jolanta Grys,
107 S Randall Rd,
Algonquin, IL 60102-9773
(847) 854-8274
(847) 854-5302

Healthcare Provider's Profile

Full NameJolanta Grys
GenderFemale
SpecialityPharmacist
Location107 S Randall Rd, Algonquin, Illinois
Accepts Medicare AssignmentsDoes not participate in Medicare Program. She may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1083062202
  • Provider Enumeration Date: 05/27/2016
  • Last Update Date: 05/27/2016

Medical Identifiers

Medical identifiers for Jolanta Grys such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1083062202NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
183500000XPharmacist 051.038010 (Illinois)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Jolanta Grys is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Jolanta Grys,
107 S Randall Rd,
Algonquin, IL 60102-9773

Ph: (847) 854-8274
Jolanta Grys,
107 S Randall Rd,
Algonquin, IL 60102-9773

Ph: (847) 854-8274

News Archive

FDA grants full approval of SYNRIBO for injection

Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration has granted full approval of SYNRIBO (omacetaxine mepesuccinate) for injection. This oncology portfolio product received an accelerated approval in October, 2012 with additional clinical trial data required to fulfill post marketing requirements set forth by the FDA.

Odyssey HealthCare announces stockholder approval for acquisition by Gentiva Health Services

Odyssey HealthCare, Inc., one of the largest providers of hospice care in the United States, today announced that its stockholders have adopted the previously announced merger agreement providing for the acquisition of Odyssey by Gentiva Health Services, Inc.. At today's special meeting of Odyssey stockholders, holders of approximately 80.4% of the outstanding shares of Odyssey common stock entitled to vote at the meeting voted to adopt the merger agreement and approve the merger.

Check and balance for neuron activity provides insight into schizophrenia, seizures

Two genes important for human development and implicated in cancer and schizophrenia also help keep a healthy balance between excitation and inhibition of brain cells, researchers say.

Simple tool right in your back pocket may help decrease type 2 diabetes risks

New University of Michigan research says that a simple tool right in your back pocket may help decrease your risk for type 2 diabetes: Text messages on your phone.

Screening tool kit to measure public facilities

Denis Anson, M.S., O.T.R., director of research and development for the Assistive Technology Research Institute (ATRI) at Misericordia University, has worn a lot of different hats in his professional career.By utilizing the expertise he's acquired during his 30 years of practice and application of assistive technology and occupational therapy strategies, Anson has devised and brought to market the Americans with Disabilities Act — Compliance Assessment Toolkit or ADA-CAT to measure whether public facilities are in compliance with the federal law that was enacted 20 years ago.

Read more News

› Verified 8 days ago


Pharmacist in Algonquin, IL

Ms. Patricia L Briick, RPH
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 4001 W Algonquin Rd, Algonquin, IL 60102
Phone: 224-569-2582    
Margeurite Sue Darguzis Thomas, R.PH.
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 1501 E Algonquin Rd, Algonquin, IL 60102
Phone: 847-658-4036    
Dr. Kenneth K Phu, PHARMA-D
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 750 S Randall Rd, Algonquin, IL 60102
Phone: 847-458-5341    Fax: 847-458-5341
Peter Koch,
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 1501 E Algonquin Rd, Algonquin, IL 60102
Phone: 847-658-4032    
Dr. Anna Ciukaj,
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 4001 W Algonquin Rd, Algonquin, IL 60102
Phone: 224-569-2582    
Mrs. Sapana Patel, PHARM.D.
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 4001 W Algonquin Rd, Algonquin, IL 60102
Phone: 224-569-2582    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.